Foot-and-mouth research at risk

Spanish law may halt research, including international vaccine collaborations, scientists warn

Written byXavier Bosch
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Spanish investigators have warned this week that a national law governing research into the foot-and-mouth disease virus could hinder international collaborations on the development of a vaccine against the veterinary pathogen.

In a letter made public last Wednesday (March 16), 135 scientists urged the government to reconsider an "incomprehensible" law that they say prevents the country's leading foot-and-mouth disease research institute from studying the causative agent.

Their protest focuses on a Spanish "royal decree" published in November that aims to enact a 2003 European Commission (EC) directive to tackle foot-and-mouth disease. Scientists were surprised to find that the Madrid-based Center of Animal Health Research (CISA), which has a long tradition on foot-and-mouth disease research, was not listed in the decree as the national center on foot-and-mouth disease. Instead, the Central Laboratory of Animal Health (LCV) near Madrid was listed as the only reference center authorized to manipulate live foot-and-mouth disease ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies